Fundraising FoxCommodore Capital — Full Portfolio
12 tracked investments · listed companies and verified rows first
Agenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL.
BiotechHealthtechLexington, US
Garo Armen(Chairman & CEO, Co-founder)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)inKaren Valentine(Executive Officer)Steven O'Day(Chief Medical Officer)in
Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalInvusLigand Pharmaceuticals+1 more
Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.
BiotechCopenhagen, US
Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)
Co-investorsAccess BiotechnologyAndreessen HorowitzBAM ElevateBay City CapitalEIR VenturesForbion+7 more
Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.
BiotechHealthtechNew York, US
Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)
Co-investorsBioAdvanceBAM ElevateBraidwellJanus Henderson InvestorsOrbiMedRA Capital+2 more
AirHelp provides technology to help air passengers claim compensation for delayed and cancelled flights.
ConsumerLegalTechSaaSTravel & HospitalityLisbon, PT
Henrik Zillmer(Founder)inNicolas Michaelsen(Founder)inGreg Roodt(Founder/CTO)inTomasz Pawliszyn(CEO)in
Co-investorsABRY PartnersAngel Capital ManagementAnya CapitalTempoCapUpslope VenturesY Combinator+15 more
A biotechnology company developing new therapies for patients with high unmet medical needs.
Biotech
Co-investorsDolby Family VenturesLifeSci Venture PartnersSofinnova VenturesThe W FundFranklin TempletonLigand Pharmaceuticals+5 more
IDRX is a regulated stablecoin backed 1:1 by the Indonesian Rupiah, letting users hold and transfer IDR value on blockchain networks for payments, trading, and Web3 financial activity.
Crypto & Web3Fintech
Co-investorsMDI VenturesRA Capital
Kronos Bio was a clinical-stage biopharmaceutical company developing small molecule therapeutics that target deregulated transcription factor networks implicated in cancer.
BiotechNew York, US
Norbert Bischofberger, Ph.D.(Executive Officer, Director)Christopher Wilfong(Executive Officer)
BoardRebecka Belldegrun, M.D.(Director)Otello Stampacchia, Ph.D.(Director)David M. Tanen(Executive Officer, Director, Promoter)Arie S. Belldegrun, M.D.(Director)
Co-investorsEcoR1 CapitalGV (Google Ventures)Nextech InvestVida VenturesBlackRockInvus+2 more
Nimbus develops wireless power technology that uses invisible infrared LED light to transmit energy across a room, with a receiver that converts the light into electricity to charge laptops, phones, and other devices.
Deep TechEnergyHardware
Michael Gorman(Founder)in
Co-investorsFoothill VenturesAccess BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value FundGV (Google Ventures)+2 more
FuseBase is an enterprise platform for deploying and managing AI agents across teams with role-based access controls, audit trails, and integrations to CRM, Slack, Teams, and email systems.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSCleveland, US
Pavel Sher(CEO)Aaron Adsit(CRO)Denis Kibalko(CTO)
Co-investorsPre-Seed to SucceedYellow Rocks!Access BiotechnologyAtlas VentureBain Capital Life SciencesBiotechnology Value Fund+3 more
Speechly provides an API that performs speech recognition and language understanding directly on user devices, reducing costs for applications that need to analyze spoken interactions in real time.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareHelsinki, FI
Otto Soderlund(Founder)inHannes Heikinheimo(Founder)in
Co-investorsCherry VenturesJoyance PartnersSNÖ VenturesTq Ventures LlcY Combinator10X Capital+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.